GSK ends Arzerra patent dispute with Genentech and nonprofit

03/27/2012 | Reuters

Genmab said marketing partner GlaxoSmithKline resolved a patent dispute with Roche Holding unit Genentech and California nonprofit City of Hope concerning Genmab's blood cancer drug Arzerra, or ofatumumab.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care